Skip to main content

Winghan Jacqueline Kwong, PharmD, PhD

Authored Items
Association Between Formulary Coverage and Use of Abuse-Deterrent Prescription Opioids, Risk for Abuse or Overdose, and Associated Healthcare Resource Utilization
Allison Petrilla, MPH, Atheer A. Kaddis, PharmD, Elizabeth Marrett, MPH, Xian Shen, PhD, MS, BS, Winghan Jacqueline Kwong, PharmD, PhD, Edmund Pezalla, MD, MPH
February 2020 Vol 13, No 1 in Original Research, Practice Management
Analysis of Real-World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia
Craig White, PhD, F. Randy Vogenberg, PhD, FASHP, James R. Lang, PharmD, MBA, Winghan Jacqueline Kwong, PharmD, PhD, Hilary Armstrong, PhD, Michael Behling, Jeffrey Niemira, Kathy Lang, PhD
September 2018 Vol 11, No 6 in Pain
Utilization of Parenteral Anticoagulants and Warfarin: Impact on the Risk of Venous Thromboembolism Recurrence in the Outpatient Setting
Jennifer Cai, MS, MPH, Winghan Jacqueline Kwong, PharmD, PhD, Ronald Preblick, PharmD, MPH, Qiaoyi Zhang, MD, PhD, James T. Kenney, RPh, MBA
November 2014 Vol 7, No 8 in Original Research
The Economic Burden of Ischemic Stroke and Major Hemorrhage in Medicare Beneficiaries with Nonvalvular Atrial Fibrillation: A Retrospective Claims Analysis
Kathryn Fitch, RN, MEd, Raymond L. Singer, MD, MMM, CPE, Jonah Broulette, ASA, MAAA, Winghan Jacqueline Kwong, PharmD, PhD
June 2014 Vol 7, No 4 in Practice Management
Utilization of Anticoagulation Therapy in Medicare Patients with Nonvalvular Atrial Fibrillation
Delete Delete, Jonah Broulette, Bruce S. Pyenson, FSA, MAAA, Kosuke Iwasaki, FIAJ, MAAA, Winghan Jacqueline Kwong, PharmD, PhD, Michael F. Murphy, MD, PhD
May/June 2012, Vol 5, No 3 in Practice Management
Last modified: April 11, 2019